tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Zevra Therapeutics Inc

ZVRA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
11.260USD
-0.060-0.53%
์ข…๊ฐ€ย 09-24 16:00๏ผˆET๏ผ‰
665.69M์‹œ๊ฐ€์ด์•ก
5.33P/E TTM

Zevra Therapeutics Inc

11.260
-0.060-0.53%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

ZVRA ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Zevra Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
665.69M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
5.33
์ฃผ๋‹น์ˆœ์ด์ต
2.11
์ˆ˜์ต
106.47M
์ˆœ์ด์ต
-105.51M
ROE
96.08%
ROA
55.05%

Zevra Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 5, 2026
EPS / ์˜ˆ์ƒ
0.14/0.11
์ˆ˜์ต / ์˜ˆ์ƒ
39.66M/33.88M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-89.60%0.14
1232.36%0.65
131.38%0.21
98.60%-0.01
386.77%1.36
85.60%-0.06
-30.09%-0.67
-132.78%-0.69
-526.55%-0.48
-3.75%-0.40
-408.33%-0.51
---0.30
---0.08
---0.38
--0.17
---0.94
----
----
----
----
์ˆ˜์ต
53.25%39.66M
77.54%36.22M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.40M
-6.79%12.04M
27.63%3.69M
-47.47%4.45M
7.84%3.42M
538.97%12.92M
0.73%2.90M
551.54%8.47M
-19.90%3.18M
-21.69%2.02M
46.26%2.87M
-89.15%1.30M
-67.28%3.96M
9.13%2.58M
2.08%1.96M
์ˆœ์ด์ต
-87.64%8.39M
1322.65%37.89M
133.10%11.83M
98.36%-544.00K
474.94%74.71M
81.36%-3.10M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
312.73%5.75M
-276.12%-6.62M
-124.80%-24.04M
96.10%-1.86M
44.34%-2.70M
41.54%-1.76M
์ˆœ์ด์ต๋ฅ 
-92.36%22.07%
788.66%104.61%
112.01%35.65%
99.77%-2.09%
164.45%288.66%
96.87%-15.19%
-92.75%-296.76%
-151.10%-899.19%
-1374.28%-447.85%
-16.62%-485.31%
-154.14%-153.96%
---358.10%
---30.38%
---416.15%
--284.37%
---399.58%
----
----
----
----
์ด ์ด์ต๋ฅ 
107.64%95.36%
149.71%213.48%
25.76%94.62%
2371.13%94.04%
404.96%45.93%
70.04%85.49%
-10.99%75.24%
-104.36%-4.14%
-116.37%-15.06%
-47.66%50.28%
-14.54%84.53%
--95.03%
--92.01%
--96.06%
--98.91%
--97.54%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-100.00%0.00%
-100.00%0.00%
-34.89%21.75%
-26.19%22.70%
-41.37%23.68%
22.41%34.79%
34.61%33.41%
-2.59%30.75%
235.27%40.39%
134.51%28.42%
123.52%24.82%
--31.57%
--12.05%
--12.12%
--11.10%
--10.71%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
53.25%39.66M
77.54%36.22M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.40M
-6.79%12.04M
27.63%3.69M
-47.47%4.45M
7.84%3.42M
538.97%12.92M
0.73%2.90M
551.54%8.47M
-19.90%3.18M
-21.69%2.02M
46.26%2.87M
-89.15%1.30M
-67.28%3.96M
9.13%2.58M
2.08%1.96M
์˜์—… ์ด์ต
236.08%16.78M
1072.51%52.15M
160.42%9.31M
115.17%4.14M
48.19%-12.33M
73.83%-5.36M
-1.71%-15.42M
-77.73%-27.31M
-280.60%-23.80M
-59.66%-20.49M
-62.75%-15.16M
-131.87%-15.36M
11.99%-6.25M
-590.21%-12.83M
-227.69%-9.31M
-198.20%-6.63M
-221.79%-7.10M
-126.71%-1.86M
11.63%-2.84M
-83.18%-2.22M
์ˆœ์ด์ต
-87.64%8.39M
1322.65%37.89M
133.10%11.83M
98.36%-544.00K
474.94%74.71M
81.36%-3.10M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
312.73%5.75M
-276.12%-6.62M
-124.80%-24.04M
96.10%-1.86M
44.34%-2.70M
41.54%-1.76M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
11.03%251.30M
181.92%229.97M
159.23%223.01M
126.38%225.12M
271.71%226.34M
29.71%81.57M
-1.05%86.03M
-27.42%99.44M
-41.13%60.89M
-39.69%62.89M
-6.35%86.94M
60.94%137.01M
18.29%103.43M
-1.42%104.28M
-19.31%92.83M
-36.77%85.13M
-35.80%87.44M
20.58%105.78M
1272.66%115.06M
1553.12%134.63M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
68.67%48.63M
74.33%47.03M
15.30%39.28M
-24.27%26.11M
-5.31%28.83M
-9.81%26.98M
-53.79%34.06M
58.80%34.48M
66.83%30.45M
91.53%29.91M
513.16%73.72M
157.55%21.71M
154.95%18.25M
430.25%15.62M
184.23%12.02M
127.99%8.43M
20.14%7.16M
-30.51%2.94M
-43.87%4.23M
-94.78%3.70M
์ด ์ž์‚ฐ
18.12%302.71M
61.30%278.58M
59.85%284.73M
41.02%270.12M
77.47%256.28M
14.16%172.71M
3.37%178.13M
37.82%191.55M
36.86%144.41M
41.92%151.28M
49.41%172.33M
16.25%138.98M
-15.08%105.52M
-15.20%106.59M
-13.24%115.34M
-12.85%119.55M
-10.48%124.26M
39.00%125.71M
1086.02%132.94M
1124.44%137.19M
๋ถ€์ฑ„ ์ด๊ณ„
-38.83%85.06M
-44.74%72.78M
-6.06%130.07M
12.46%136.95M
24.23%139.05M
28.52%131.69M
25.35%138.46M
70.29%121.78M
202.36%111.93M
191.17%102.47M
174.65%110.46M
177.64%71.51M
47.93%37.02M
736.49%35.19M
590.71%40.22M
372.69%25.76M
207.66%25.02M
-31.97%4.21M
-92.50%5.82M
-92.59%5.45M
์ž๋ณธ ์ด๊ณ„
85.66%217.65M
401.68%205.80M
289.90%154.66M
90.86%133.16M
260.95%117.23M
-15.97%41.02M
-35.88%39.67M
3.41%69.77M
-52.59%32.48M
-31.63%48.82M
-17.65%61.86M
-28.07%67.47M
-30.97%68.50M
-41.23%71.40M
-40.91%75.12M
-28.80%93.79M
-24.05%99.23M
44.21%121.50M
291.41%127.12M
311.36%131.74M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
572.98%17.03M
174.70%6.14M
133.94%5.52M
125.96%4.71M
81.16%-3.60M
49.14%-8.22M
-0.57%-16.25M
-291.98%-18.14M
-119.54%-19.11M
-299.63%-16.16M
-262.12%-16.16M
29.86%-4.63M
-108.63%-8.70M
-13.85%-4.04M
-426.18%-4.46M
-141.68%-6.60M
-125.13%-4.17M
-37.39%-3.55M
19.92%-848.00K
-159.75%-2.73M
์ˆœํˆฌ์ž
163.54%31.45M
655.25%79.62M
104.15%227.00K
85.41%-4.58M
9351.16%11.93M
-28.74%10.54M
-151.69%-5.47M
29.47%-31.35M
-100.38%-129.00K
184.27%14.79M
16901.59%10.59M
-16444.12%-44.46M
202.89%34.04M
-356.21%-17.55M
99.59%-63.00K
6900.00%272.00K
-40739.51%-33.08M
---3.85M
-59280.77%-15.44M
---4.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
14.77%1.58M
-3385.87%-52.80M
219.85%2.55M
-89.92%6.53M
-90.99%1.38M
32.05%1.61M
-84.09%796.00K
146.64%64.77M
1511.99%15.33M
132.45%1.22M
2047.08%5.00M
6520.29%26.26M
-93.12%951.00K
20.77%-3.75M
91.05%-257.00K
-121.06%-409.00K
-65.23%13.82M
-106.37%-4.73M
-6139.13%-2.87M
3907.84%1.94M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Zevra Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 106.47M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.61M์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 223.01M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 159.23์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 284.73M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 59.85์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 130.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.06์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 154.66M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 289.90์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -4.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 95.13์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 18.13M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 181.80์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Zevra Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 12.06M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -85.31์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 1.40์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 161.49์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 77.58M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 173.53์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 78.17์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 117.49์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 80.89์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 91.77์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 21.75์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.89์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ 79.85์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 138.42์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 35.96์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 159.73์ž…๋‹ˆ๋‹ค.

Zevra Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Zevra Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -4.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 95.13์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ